Recursion Pharmaceuticals (RXRX) News Today $5.57 +0.16 (+2.90%) As of 11:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RXRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Purchased by Blair William & Co. ILAugust 12 at 3:45 AM | marketbeat.comRecursion Pharmaceuticals’ Earnings Call Highlights Progress and ChallengesAugust 11 at 9:41 AM | theglobeandmail.com3 Brilliant Growth Stocks to Buy Now and Hold for the Long TermAugust 10 at 5:20 AM | fool.comHead to Head Comparison: Recursion Pharmaceuticals (NASDAQ:RXRX) & Addex Therapeutics (NASDAQ:ADXN)August 10 at 2:10 AM | americanbankingnews.comLeerink Partnrs Has Positive Outlook of RXRX Q3 EarningsAugust 10 at 2:31 AM | americanbankingnews.comEquities Analysts Set Expectations for RXRX Q3 EarningsAugust 9, 2025 | marketbeat.comHeadlands Technologies LLC Buys 76,536 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)August 9, 2025 | marketbeat.comIs Recursion Pharmaceuticals (RXRX) Nvidia's Key AI Biotech Stake a Buy Amid Innovation Surge?August 8, 2025 | 247wallst.comBroker Revenue Forecasts For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Are Surging HigherAugust 6, 2025 | finance.yahoo.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | msn.comRecursion Pharmaceuticals (NASDAQ:RXRX) Releases Earnings Results, Misses Expectations By $0.06 EPSAugust 6, 2025 | marketbeat.com5RXRX : Recursion Pharmaceuticals Earnings PreviewAugust 6, 2025 | benzinga.comRecursion (RXRX) Q2 Revenue Jumps 33%August 6, 2025 | theglobeandmail.comRecursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?August 6, 2025 | msn.comWhy Recursion Pharmaceuticals Stock Tanked on TuesdayAugust 5, 2025 | fool.comRecursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comRecursion Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 5, 2025 | globenewswire.comIQ EQ FUND MANAGEMENT IRELAND Ltd Buys 186,767 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)August 5, 2025 | marketbeat.com2 Beaten-Down Stocks With Incredible Upside PotentialAugust 3, 2025 | fool.comRecursion Pharmaceuticals (RXRX) Price Surges 9% Over Past MonthAugust 2, 2025 | finance.yahoo.comRecursion Pharmaceuticals (RXRX) Expected to Announce Quarterly Earnings on TuesdayAugust 1, 2025 | marketbeat.comRecursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5thJuly 29, 2025 | globenewswire.comWhy Recursion Pharmaceuticals Stock Got Mashed on MondayJuly 28, 2025 | fool.comTempus AI (TEM) vs. Recursion (RXRX): Which AI Biotech Stock Is Better?July 28, 2025 | 247wallst.com62,691 Shares in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Purchased by Cerity Partners LLCJuly 28, 2025 | marketbeat.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Purchased by ARK Investment Management LLCJuly 27, 2025 | marketbeat.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Sold by Nikko Asset Management Americas Inc.July 27, 2025 | marketbeat.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Sold by Baillie Gifford & Co.July 27, 2025 | marketbeat.comThe Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.July 26, 2025 | fool.comHow Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big PharmaJuly 25, 2025 | benzinga.comRecursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 EarningsJuly 22, 2025 | insidermonkey.comPier 88 Investment Partners LLC Sells 66,940 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)July 22, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Up - Time to Buy?July 21, 2025 | marketbeat.comRecursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder HypophosphatasiaJuly 21, 2025 | finance.yahoo.comQ2 Earnings Estimate for RXRX Issued By Leerink PartnrsJuly 21, 2025 | marketbeat.comRecursion Pharmaceuticals (RXRX) Sees 14% Price Surge Over Last MonthJuly 20, 2025 | finance.yahoo.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Consensus Recommendation of "Hold" from AnalystsJuly 19, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Up 9.4% - Here's WhyJuly 18, 2025 | marketbeat.comD.A. Davidson & CO. Raises Stock Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)July 11, 2025 | marketbeat.comMorgan Stanley Assumes Coverage of Recursion Pharmaceuticals (RXRX) Stock with an Equal Weight RatingJuly 10, 2025 | msn.comRecursion Pharmaceuticals (RXRX) Rallies 8.7% on HypophosphatasiaJuly 9, 2025 | insidermonkey.comRecursion Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RXRX)July 9, 2025 | marketbeat.comRallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25MJuly 9, 2025 | finance.yahoo.com10 Under-the-Radar Tech Stocks With Incredible Growth PotentialJuly 9, 2025 | fool.comRecursion Pharmaceuticals (RXRX) Drops on Profit-TakingJuly 8, 2025 | insidermonkey.comRecursion Pharmaceuticals: Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for HypophosphatasiaJuly 8, 2025 | finanznachrichten.deRecursion Pharmaceuticals Stock Gains on Plans to Buy Drug-Development Interest from RallybioJuly 8, 2025 | marketwatch.comRecursion Pharmaceuticals stock soars after acquiring HPP treatment from RallybioJuly 8, 2025 | in.investing.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading 6.7% Higher - Should You Buy?July 8, 2025 | marketbeat.com10 Stocks Crash Hard Alongside Wall StreetJuly 8, 2025 | insidermonkey.com Get Recursion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos RXRX Media Mentions By Week RXRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXRX News Sentiment▼0.370.75▲Average Medical News Sentiment RXRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXRX Articles This Week▼1510▲RXRX Articles Average Week Get Recursion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Elanco Animal Health News Today Blueprint Medicines News Today Roivant Sciences News Today Grifols News Today Legend Biotech News Today Revolution Medicines News Today Rhythm Pharmaceuticals News Today Avidity Biosciences News Today Nuvalent News Today Axsome Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXRX) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access